Stock market announcement archive

Lifecare Q1 2024 Report – From preparations phase to pilot production

May 8, 2024
Bergen, Norway, May 5th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q1 financial report and operational update. Lifecare Q1 report 2024 is available here Lifecare has been delivering milestones on a continuous basis over a long period. The company has […]
Read more

Lifecare Q4 2023 Report – Steady course

February 27, 2024
Bergen, Norway, February 27th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q4 financial report and operational update. Lifecare holds steady a course towards the upcoming automated pilot production. The first three quarters of 2023, Lifecare reported on huge achievements both […]
Read more

LIFE: Lifecare Q3 2023 Report

November 14, 2023
Bergen, Norway, November 14th, 2023: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q3 financial report and operational update. Lifecare completed Q3 with many important technology and operational achievements. The Company is shifting focus from conducting research and development to focusing on […]
Read more

LIFE: Q4 2022 interim report and webcast

February 28, 2023
Bergen, Norway 28 February 2023Today Lifecare publish Q4 2022 interim report. The consolidated group financials show a revenue in Q4 of 5.31 MNOK, compared to1,6 MNOK in Q4 2021. The unaudited interim figures for 2022 show a revenue of20,7 MNOK compared to 1,6 MNOK in 2021. The report is attached to this releaseand are also […]
Read more

Lifecare Q3 2022: All-time high revenue

December 6, 2022
Bergen, Norway 6.12.2022Today Lifecare announces all-time high revenue in their financial reporting forQ3 2022. - We are pleased to see a positive outcome of the investments we havemade. Furthermore, this provides a base for LifecareŽs continued research andproduct development, says CEO Joacim Holter.The consolidated group financials show a revenue of 15,4 MNOK for the first […]
Read more

Reminder – Lifecare Q3 financial and operational update

December 6, 2022
Bergen, Norway 6 December 2022 Lifecare AS will present Q3 2022 financial and operational status in a webcasttoday, Tuesday 6 December. The webcast will be for all shareholders andinterested parties at 13:00 - 14:00 CET. Lifecare CEO Joacim Holter will participate in the webcast.There will be a Q&A session following the presentation. The webcast will […]
Read more

Lifecare Q3 report and webcast – Newsletter

December 1, 2022
Bergen, Norway 1 December 2022 Lifecare AS will present Q3 2022 financial and operational status in a webcastTuesday 6 December. For more information of the webcast and other news, read Lifecare's latestnewsletter: https://lifecare.no/news/information-from-lifecare-november-2022/This is Lifecare: Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people […]
Read more

Lifecare semi-annual report – strategic measures lead to strong increase in external revenue and increased operational capacity

August 25, 2022
Bergen, 25 August 2022. Today, Lifecare present strong financial results following the first half-yearwith operational activities in two German subsidiaries as part of the LifecareGroup. The external revenue in 1H 2022 reached a total of 8,7MNOK, representingan increase of +8,7MNOK from 1H 2021 (from 0,0 MNOK) and +7,1MNOK from EY 2021(from 1,6MNOK). A steep increase […]
Read more

LIFE: Annual report 2021 and webcast

April 21, 2022
Bergen, Norway 21 April 2022Today, Lifecare 2021 annual report is published. 2021 was marked by severalimportant milestones: o Regulatory approval for first-in-human pilot clinical trials o Restructuring the organization - controlling development operationso Reinforced Patent Protection and IPo Successful Capital IncreaseThe report is subject to approval by the company's general meeting on 6 May2022.Lifecare AS' […]
Read more